Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enolase-phosphatase 1 (ENOPH1) is a bifunctional enzyme involved in the methionine salvage pathway, catalyzing both the enolization and phosphatase activities required for converting 2,3-diketo-5-methylthio-1-phosphopentane to downstream products[1][7]. It possesses acireductone synthase activity and is localized in the cytosol[5]. ENOPH1 has been identified as a potential indicator for malignant glioma, where it appears to promote cell proliferation and migration[4][5]. No known small-molecule modulators or approved drugs targeting ENOPH1 have been reported to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enolase-phosphatase 1 (ENOPH1).